z-logo
open-access-imgOpen Access
Adverse events of benralizumab in moderate to severe eosinophilic asthma
Author(s) -
Wanshu Liu,
Xuesu Ma,
Wenjin Zhou
Publication year - 2019
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000015868
Subject(s) - medicine , benralizumab , relative risk , placebo , adverse effect , asthma , exacerbation , gastroenterology , confidence interval , mepolizumab , eosinophil , pathology , alternative medicine
Supplemental Digital Content is available in the text

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here